Annual Report

Amylyx Pharmaceuticals, Inc. Filed 2024-02-22 Acc 0000950170-24-018447

Documents 1

2025-03-04 10-K Annual Report
2024-02-28 4 Co-Chief Executive Officer acquired 126,667 shares (grant or award)
2024-02-27 4 Chief Legal Officer sold 2,838 shares at $18.76 ($53,231)
2024-02-22 S-8 Securities Offered to Employees in Benefit Plans
2024-02-22 10-K Annual Report
2024-02-22 8-K Results of operations
2023-03-13 10-K Annual Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading amlx-20231231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…